Your browser doesn't support javascript.
loading
Differences in the Presentation and Progression of Parkinson's Disease by Sex.
Iwaki, Hirotaka; Blauwendraat, Cornelis; Leonard, Hampton L; Makarious, Mary B; Kim, Jonggeol J; Liu, Ganqiang; Maple-Grødem, Jodi; Corvol, Jean-Christophe; Pihlstrøm, Lasse; van Nimwegen, Marlies; Smolensky, Luba; Amondikar, Ninad; Hutten, Samantha J; Frasier, Mark; Nguyen, Khanh-Dung H; Rick, Jacqueline; Eberly, Shirley; Faghri, Faraz; Auinger, Peggy; Scott, Kirsten M; Wijeyekoon, Ruwani; Van Deerlin, Vivianna M; Hernandez, Dena G; Gibbs, Raphael J; Day-Williams, Aaron G; Brice, Alexis; Alves, Guido; Noyce, Alastair J; Tysnes, Ole-Bjørn; Evans, Jonathan R; Breen, David P; Estrada, Karol; Wegel, Claire E; Danjou, Fabrice; Simon, David K; Andreassen, Ole A; Ravina, Bernard; Toft, Mathias; Heutink, Peter; Bloem, Bastiaan R; Weintraub, Daniel; Barker, Roger A; Williams-Gray, Caroline H; van de Warrenburg, Bart P; Van Hilten, Jacobus J; Scherzer, Clemens R; Singleton, Andrew B; Nalls, Mike A.
Afiliación
  • Iwaki H; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Blauwendraat C; Data Tecnica International, Glen Echo, Maryland, USA.
  • Leonard HL; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Makarious MB; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Kim JJ; Data Tecnica International, Glen Echo, Maryland, USA.
  • Liu G; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Maple-Grødem J; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Corvol JC; School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Pihlstrøm L; Advanced Center for Parkinson's Disease Research, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • van Nimwegen M; Precision Neurology Program, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Smolensky L; The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
  • Amondikar N; Department of Chemistry, Bioscience and Environmental Engineering, University in Stavanger, Stavanger, Norway.
  • Hutten SJ; Assistance-Publique Hôpitaux de Paris, ICM, INSERM UMRS 1127, CNRS 7225, ICM, Department of Neurology and CIC Neurosciences, Pitié-Salpêtrière Hospital, Paris, France.
  • Frasier M; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Nguyen KH; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Rick J; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
  • Eberly S; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
  • Faghri F; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
  • Auinger P; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
  • Scott KM; Translational Genome Sciences, Biogen, Cambridge, Massachusetts, USA.
  • Wijeyekoon R; Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Van Deerlin VM; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.
  • Hernandez DG; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Gibbs RJ; Department of Neurology, Center for Health + Technology, University of Rochester, Rochester, New York, USA.
  • Day-Williams AG; Department of Clinical Neurosciences, University of Cambridge, John van Geest Centre for Brain Repair, Cambridge, UK.
  • Brice A; Department of Clinical Neurosciences, University of Cambridge, John van Geest Centre for Brain Repair, Cambridge, UK.
  • Alves G; Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Noyce AJ; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Tysnes OB; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • Evans JR; Flagship Labs 60 Inc, Cambridge, Massachusetts, USA.
  • Breen DP; Statistical Genetics, Biogen, Cambridge, Massachusetts, USA.
  • Estrada K; Institut du cerveau et de la moelle épinière ICM, Paris, France.
  • Wegel CE; Sorbonne Université SU, Paris, France.
  • Danjou F; INSERM UMR1127, Paris, France.
  • Simon DK; The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
  • Andreassen OA; Department of Chemistry, Bioscience and Environmental Engineering, University in Stavanger, Stavanger, Norway.
  • Ravina B; Department of Neurology, Stavanger University Hospital, Stavanger, Norway.
  • Toft M; Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Heutink P; Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.
  • Bloem BR; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Weintraub D; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Barker RA; Department of Neurology, Nottingham University NHS Trust, Nottingham, UK.
  • Williams-Gray CH; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, Scotland, UK.
  • van de Warrenburg BP; Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, UK.
  • Van Hilten JJ; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  • Scherzer CR; Translational Genome Sciences, Biogen, Cambridge, Massachusetts, USA.
  • Singleton AB; Department of Medical and Molecular Genetics, Indiana University, Indianapolis, Indiana, USA.
  • Nalls MA; Institut du cerveau et de la moelle épinière ICM, Paris, France.
Mov Disord ; 36(1): 106-117, 2021 01.
Article en En | MEDLINE | ID: mdl-33002231
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Disfunción Cognitiva Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Mov Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos